A rare cardiac involvement: hepatocellular carcinoma

In 2010, the ASCI provided recommendations for cardiac CT and MRI. This document reflects an updating of the prior 2010 ASCI appropriate use criteria (AUC). In 2016, the ASCI formed a new working group for revision of AUC on noninvasive cardiac imaging. A major change that we made in this document is the rating of various noninvasive tests (exercise electrocardiogram, echocardiography, positron emission tomography, single-photon emission computed tomography, radionuclide imaging, cardiac magnetic resonance, cardiac computed tomography/angiography), compared side by side for their applications in various clinical scenarios. Ninety-five clinical scenarios were developed from the selected eight pre-existing guidelines and classified into four sections as follows: 1) detection of coronary artery disease-symptomatic or asymptomatic, 2) cardiac evaluation in various clinical scenarios, 3) use of imaging modality according to prior testing, and 4) evaluation of cardiac structure and function. Ninetyfive clinical scenarios were scored by a separate rating committee on a scale of 1-9 to designate appropriate, uncertain, or inappropriate according to modified Delphi method. Overall, the AUC ratings for CT were higher than those of previous guidelines. These new AUC are intended to provide guidance for clinicians when it comes to making a reasonable testing choice among the available testing modalities for various cardiac diseases. These new AUC are also unique as most AUC for noninvasive imaging include only one imaging technique. As cardiac imaging is multimodality in nature we believe that these AUC can be more useful in clinical practice decision making. SE 03 CV-02 A rare cardiac involvement: hepatocellular carcinoma Gokhan Polat, Hayri Ogul, Berhan Pirimoglu, Recep Sade, Suat Eren, Akin Levent, Mecit Kantarci, Serhat Kaya Ataturk University, Turkey. [email protected]